OBSERVATIONS RELATED TO THE PATHOGENESIS OF DENGUE HEMORRHAGIC FEVER.
ANTIGENIC AND BIOLOGIC PROPERTIES OF DENGUE VIRUSES AND THEIR ASSOCIATION WITH DISEASE RESPONSE IN THE HOSTt
One of the hypotheses invoked to explain the occurrence of different diseases associated with dengue virus infection is that dengue viruses differ in virulence properties. Observations on virologically studied dengue fever and dengue hemorrhagic fever (DHF)"'8 patients have reasonably established that both of these diseases are associated with dengue viruses of all known antigenic types. The possibility that virus strains within the same type differ in their virulence properties and that these differences might be genetically associated with surface antigen or other readily measured markers has not been examined. This hypothesis was the initiating motivation for this study. Using single lots of mouse immune ascitic fluids, we tested a large number of dengue viruses by a plaque reduction neutralization test and the results were compared with the disease response and geographic origin of virus strains. A few observations on biologic properties of the examined dengue virus strains are included.
MATERIALS AND METHODS

Plaque reduction test
The production of LLC-MK2 monolayers, the techniques of plaque assay and the plaque reduction neutralization test have been given elsewhere.' In all tests, six replicate 2 oz. plaque bottles were used. All neutralization tests reported in this paper were performed by incubating serum and virus mixtures at 22-250C. for exactly 60 minutes. Reactions were stopped by dilution of serum-virus mixtures to 1:100 in chilled 0.75% bovine albumin-phosphate buffered saline, pH 7.8-8.0 (BAPS) or 20% heat inactivated agamma calf serum in phosphate buffered saline, pH 7.8-8.9. Residual virus was incubated on cell sheets for 90 minutes at 370C. before agar overlay.
Viruses
Thailand viruses studied were recovered in suckling mice or tissue culture by methods described previously.'0 Also studied were 19 dengue virus strains that had been isolated in other Asian countries and in the 1963 Caribbean outbreak. Data on the year of isolation, disease association, country of origin, and donors of these latter strains are summarized in Table 1 .
Group 3 prototype dengue viruses described in a previous communication were used.' Preparation and standardization of immune mouse ascitic fluid (MAF) * In preliminary studies it had been observed that neutralizing antibody to a variety of high and low mouse passage dengue strains of types 1, 3, or 4 viruses could not be consistently demonstrated at 1:10 or higher dilutions of mouse ascitic fluids (MAF) when only a single stimulus was given or two antigenic stimuli were given at an interval of one week. MAF with significant neutralizing activity at these dilutions could be produced by three weekly intraperitoneal inoculations of 0.5 ml. of a 10% saline suspension of mouse brain virus seed. Immune fluids were produced by mixing the third administered virus suspension with 0.5 ml. of ascitic fluid containing S-180 cells.' Seven to 20 days later mouse ascitic fluids were tapped. Since other data had suggested the antigenic similarity of TH-Sman and TH-36 with dengue 1 and 2, respectively,9 only dengue 1-4 viruses were used in the preparation of immune MAF. 
Nonspecific inhibitors of dengue viruses
In early experiments it was observed that after incubation of virus with 1:20 or 1:40 dilutions of normal mouse ascitic fluids for one hour at 25°C. or 37°C. there was significant reduction in dengue plaque counts. Heating mouse ascitic fluids at 56°C. for 30 minutes only slightly reduced this dengue neutralizing effect. Acetone extraction removed nonspecific dengue neutralizing substances at ascitic fluid dilutions of 1:5 and above. Broadly reactive, acetone extractable dengue neutralizing substances were found in individual sera from Macaca mulatta, humans, rabbits, and guinea pigs. Significant variation with different individuals was observed. In the following studies, immune and control ascitic fluids were acetone extracted and diluted to at least 1:10 before use. Tables 2-5 show percent plaque reduction obtained with identical lots and dilutions of immune ascitic fluids when incubated with a large number of dengue strains of diverse geographic or disease origin. Results are grouped by the typing result obtained in other tests or the "major" neutralization reaction obtained. Plaque reduction of prototype dengue 1-4 viruses with homologous MAF at 25°C. for 60 minutes are shown in Table  2 . These data should be compared with results in other tables. Table 2 shows that 8/14 dengue 1 strains were significantly neutralized by dengue 3 MAF. Less frequently (2/14), cross reactions occurred with dengue 4 MAF. In the limited number of strains examined there did not appear to be any particular antigenic pattern associated with disease response or area of origin of the strain. Prototype dengue 1 and TH-Sman differed in their reactions with dengue 4 MAF.
Study of strains
Results of testing dengue 2 strains are presented in Table 3 . The majority of recent isolates differed in their reactivity pattern from the prototype strain (TR 1751); 4/17, 5/17 and 11/17 were significantly neutralized by dengue 1, 3, and 4 MAF, respectively. It was of interest that all four dengue 2 strains from patients with diseases described as dengue fever showed no antigenic crossing with dengue 4 antiserum. Of 13 viruses recovered from patients clinically diagnosed as hemorrhagic fever (all from Thailand) and two viruses recovered from Thailand mosquitoes, all but two strains were significantly neutralized by dengue 4 MAF. A variety of cross reactions with dengue 1 and 3 MAF were also noted. These did not appear to occur in any consistent pattern. As indicated in Table 4 , four of six dengue type 3 strains were significantly neutralized by dengue 1 MAF. Neutralization by dengue 2 and 4 immune MAF were noted with two strains each.
Despite frequent neutralization of other viruses by dengue 4 MAF, of seven dengue 4 strains analyzed, only once was significant neutralization noted (by dengue 2 immune MAF). The strains tested were not always well neutralized by prototype dengue 4 MAF. While the homologous neutralizing activity of dengue 4 MAF was not high, it frequently neutralized an equal proportion of strains of other dengue virus types.
Further experience suggested that the patterns of neutralization observed in examined dengue virus strains might vary in different virus seed preparations. In experimental data described in Table 6 , mouse brain seeds were made from washings of isolated plaques (only one plaque per bottle) from a number of terminal dilutions of dengue 2 strain 64412. These viruses were recovered from plaques even after two weeks incubation of infected cells at 25°C. Selected strains were inoculated intracerebrally into suckling mice. Brains were harvested and seeds tested against the standard dilutions of dengue 1-4 antisera. Marked differences in antigenic reaction patterns were noted in virus preparations obtained from different "clones." These data were reproducible.
In a second experiment, three passage levels of 4989-62 dengue 2 strain were tested against dengue 1-4 antisera. Again, each preparation showed different reaction patterns with dengue prototype immune MAF.
Biologic properties of dengue viruses
Among the virus strains examined there appeared to be a consistent relationship between plaque size, plaque definition, and host passage. Thus, nine days after inoculation of LLC-MK2 bottles, high mouse passage dengue 1 (Hawaii) produced indistinct plaques with irregular margins averaging 1-2 mm. in diameter. Dengue 3 (H-87) at 26th mouse passage frequently produced hazy, ill defined plaques, 2-3 mm. in diameter. Tiny "satellite" plaques were frequently seen. Limited observations were made on the susceptibility of dengue viruses to nonspecific inhibitors. Dengue 2 (TR 1751 strain) at 70+ mouse passage was highly susceptible to acetone-extractable inhibitors found at 1:10-1:30 dilutions of normal monkey serum or plasma. Two tissue culture passaged dengue 2 strains (1950-63 and 16681) recovered from hemorrhagic fever patients in Thailand were not significantly neutralized by normal monkey serum or plasma at dilutions of 1:10 or higher. Although a large number of low mouse passage dengue viruses were found to be inhibited by normal mouse ascitic fluid at dilution of 1:10 or higher, a systematic study of this phenomenon has not been made.
Dengue virus temperature sensitivity was studied with a large number of dengue strains. Results are summarized in Tables 2-6 . Twelve bottles each were inoculated with serial tenfold dilutions of dengue virus. One half of inoculated bottles at each dilution, chosen randomly, were incubated at 39CG. for seven days and the other half at 35°C. Differences in plaque counts observed were always in the direction of lower counts in bottles incubated at higher temperature. Results are expressed as percentile plaque reduction in bottles incubated at 39°C. compared with 35°C. Dengue strains showing .5 or greater plaque reduction at 39°C. arbitrarily are defined as temperature sensitive. Eleven of 13 dengue 1 strains, three of four dengue 3 strains, four of six dengue 4 strains, but only four of 18 dengue 2 strains, were "temperature sensitive." It was of interest that three of four temperature sensitive dengue 2 strains were recovered from patients with a diagnosis of hemorrhagic fever. Several "clones" of a dengue 2 virus and different mouse passage levels of another dengue 2 virus were studied (Table 6 ). Temperature sensitivity characteristics were retained by all subpopulations.
DISCUSSION
Antibody obtained from mice receiving multiple separate antigenic stimuli with the same virus when tested against strains of dengue viruses in a plaque reduction neutralization test (PRNT) did not separate dengue viruses into clearly distinct types with little cross reaction as have other methods.""9ll Cross reactions between dengue viruses and heterologous antisera were minimal when antibody to low mouse passage dengue strains prepared by two injections of mice was tested by complement-fixation against prototype dengue antigens,9 when dengue viruses were tested by PRNT against monkey antisera,89 or when dengue viruses were identified by micro precipitin in agar' or immunoelectrophoresis.'5 The use of multiple antigenic stimuli for production of antibody in our study appears to have increased the amount of heterotypic reaction. Heterotypic neutralization, in some instances, was stronger than that in the homologous system.
Strains within the major dengue serotype groups differed markedly in their reactions with heterotypic dengue antisera. In demonstrating antigenic heterogeneity of dengue strains our results are in accord with those of Ibraham and Hammon""'7 who showed that dengue 1 or dengue 2 viruses and antisera when tested reciprocally with TH-Sman or TH-36 viruses and antisera contained distinguishing precipitin reaction both by Ochterlony and immunoelectrophoresis methods. The variation in antigenic patterns observed in our studies can be explained in a number of different ways. A simple hypothesis is that dengue virions contain "major" and "minor" antigens. Minor antigens might be either less reactive, distributed in less accessible sites or present at lower concentrations on virions than "major"
antigens. Dengue viruses of one type contain "minor" antigens that are similar or identical to "major" antigens on other dengue virus types.
Between dengue 1 and 3 viruses and antisera, reciprocal cross reactions were observed with high frequency. This suggests a similarity of 1 and 3 "major" antigens. There was a marked inhomogeneity in neutralization of dengue 2 strains by antibodies to dengue 1, 3 and 4 viruses. By our hypothesis this could be explained by variation in the occurrence of "minor" antigens on dengue virions. A one way cross between dengue 4 antisera and dengue 2 viruses was observed frequently.
The original purpose of this study was to examine for variations between dengue virus strains of the same serotype that could be correlated with geographic origin or disease response in the host. Insufficient virus strains from various areas or diseased hosts were studied to attain this goal. From the heterogenity of patterns observed, it is unlikely that consistent antigenic differences would have been detected had a larger collection been examined. Russell, et al.8 also examined dengue strains from Thailand, Vietnam, Pakistan, and Puerto Rico and failed to find major antigenic differences between dengue strains of the same virus type occurring in different areas. An observation made that may be worthy of further study is that dengue 2 viruses neutralized by dengue 4 antibody were recovered only from hemorrhagic fever patients and not from patients with a dengue fever response during infection.
The heterogeneity of neutralization reactions obtained with "clones" of 64412 strain of dengue 2 virus and several different mouse passages of 4989-62 dengue 2 virus strongly suggests that the antigenic pattern for any particular lot of virus seed may not be representative of the antigenic composition of the original virus population that caused human infection. It is known that when human adapted dengue viruses are passaged in laboratory hosts, biological properties change. For example, Sabin has shown that several strains of dengue viruses rapidly lost pathogenicity for humans following intracerebral passage of virus in mice. '8 We have presented data indicating that high mouse passage dengue viruses produce small and ill defined plaques in monkey kidney cells while other strains of the same type of virus passaged only in primate cells produced uniformly larger plaques. A dengue 4 mouse passage strain isolated in mice on subsequent passage into a monkey changed from a medium to a large plaque variant. The work of Henderson, et al."9 suggests that antigenic variation during host passage may be a general phenomenon with arboviruses.
Although the "original" antigenic pattern of the dengue viruses that we have studied apparently cannot be known, it is not improbable that the antigenic heterogeneity observed most frequently in dengue 2, 3 and 1 viruses also occurs in natural virus populations. It is interesting to speculate on the possible creation of dengue antigenic heterogeneity in nature by a sharing of genetic material between dengue viruses during the simultaneous dengue infections that almost certainly occur in highly endemic areas or, contrarily, by the selection that may take place when a dengue virus infection occurs in an individual with pre-existing group B arbovirus antibody. Some important system of antigen sharing must exist to account for the cross protection induced in humans by dengue infection.' Shared antigens may also result in sensitization phenomena. This has received fuller discussion elsewhere. 2' Once it is determined whether antigenic patterns stabilize in populations derived from a single viable virus or whether antigenic patterns change in some regular fashion on passage in laboratory hosts, it should be possible to use antigenic studies of dengue viruses as a rational method for study of cross protection and cross sensitization phenomena. Since the described system of antigen analysis requires very small quantities of reagents, it may be possible to use viremic human serum itself for antigenic comparisons.
SUMMARY
Forty-nine strains of dengue viruses, types 1-4, of diverse geographic origin recovered from hosts with disease of varying severity were studied 290 Volume 42, April, 1970 for plaque reduction produced by identical lots of dengue type 14 mouse immune ascitic fluids (MAF). Patterns of neutralization varied markedly among dengue strains. Of the two types (dengue 1 and 2) with the largest number of strains available for analysis, dengue 2 viruses were more frequently neutralized singly or in combination by heterologous dengue immune MAF. Dengue 4 viruses were rarely neutralized by heterologous antibody. Reciprocal cross neutralization between strains of dengue 1 and dengue 3 viruses and immune MAF was frequent. Dengue 4 immune MAF significantly neutralized 11/18 dengue 2 strains; this pattern was absent in 4 dengue strains recovered from classic dengue fever cases.
Because the pattern of neutralization by heterologous antibody varied in virus populations derived from a single strain and in the same virus strain studied at different mouse passage levels, it was unknown whether the observed neutralization results represented the antigenic pattern of the original virus population in the diseased host. No conclusions could be reached concerning correlation of specific antigenic pattern and type of response of host to dengue infection.
The plaque forming property of dengue 2 viruses was stable at 39°C. more frequently than it was in other dengue types. Dengue strains at high mouse passage produced smaller plaques than viruses of the same type at lower mouse passage or when recovered in tissue culture. Reversion from small to large plaque variants was observed by single passage of a suckling mouse brain adapted dengue 4 strain into a sub-human primate.
